Previous close | 5.2000 |
Open | 3.8300 |
Bid | 3.7000 |
Ask | 8.2000 |
Strike | 260.00 |
Expiry date | 2025-06-20 |
Day's range | 2.6000 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | 2 |
On May 2, 2024, Director Sangeeta Bhatia sold 467 shares of Vertex Pharmaceuticals Inc (NASDAQ:VRTX) as reported in a recent SEC Filing.
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $400.16, representing a -0.49% change from its previous close.
Arcus Biosciences (RCUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.